Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial
NCT: NCT03584022 · ACTIVE_NOT_RECRUITING
Brief Summary
This is safety study. Subjects will be undergoing the surgical procedure of nerve biopsy. After routine surgery without grafting, patients develop swelling, redness, tenderness and dysesthesia at the biopsy site. In order to determine whether grafting is safe compared to not repairing the nerve, it is necessary to compare treated vs. untreated patients using systematic, sensitive and reproducible criteria.
Frequently Asked Questions
What is Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial?
Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial is a clinical trial registered under NCT03584022. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT03584022?
The current status of NCT03584022 (Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial) is: ACTIVE_NOT_RECRUITING.
When did Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial start?
Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial started on 2018-11-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.